• Je něco špatně v tomto záznamu ?

Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition

D. Turner, FM. Ruemmele, E. Orlanski-Meyer, AM. Griffiths, JM. de Carpi, J. Bronsky, G. Veres, M. Aloi, C. Strisciuglio, CP. Braegger, A. Assa, C. Romano, S. Hussey, M. Stanton, M. Pakarinen, L. de Ridder, K. Katsanos, N. Croft, V. Navas-López,...

. 2018 ; 67 (2) : 257-291. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu konsensus - konference, časopisecké články, směrnice pro lékařskou praxi

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045346

Grantová podpora
G0800675 Medical Research Council - United Kingdom

BACKGROUND: The contemporary management of ambulatory ulcerative colitis (UC) continues to be challenging with ∼20% of children needing a colectomy within childhood years. We thus aimed to standardize daily treatment of pediatric UC and inflammatory bowel diseases (IBD)-unclassified through detailed recommendations and practice points. METHODS: These guidelines are a joint effort of the European Crohn's and Colitis Organization (ECCO) and the Paediatric IBD Porto group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). An extensive literature search with subsequent evidence appraisal using robust methodology was performed before 2 face-to-face meetings. All 40 included recommendations and 86 practice points were endorsed by 43 experts in Paediatric IBD with at least an 88% consensus rate. RESULTS: These guidelines discuss how to optimize the use of mesalamine (including topical), systemic and locally active steroids, thiopurines and, for more severe disease, biologics. The use of other emerging therapies and the role of surgery are also covered. Algorithms are provided to aid therapeutic decision-making based on clinical assessment and the Paediatric UC Activity Index (PUCAI). Advice on contemporary therapeutic targets incorporating the use of calprotectin and the role of therapeutic drug monitoring are presented, as well as other management considerations around pouchitis, extraintestinal manifestations, nutrition, growth, psychology, and transition. A brief section on disease classification using the PIBD-classes criteria and IBD-unclassified is also part of these guidelines. CONCLUSIONS: These guidelines provide a guide to clinicians managing children with UC and IBD-unclassified management to provide modern management strategies while maintaining vigilance around appropriate outcomes and safety issues.

1st Department of Pediatrics Semmelweis University Budapest Hungary

Barts and the London School of Medicine Queen Mary University of London London UK

BC Children's Hospital University of British Columbia Vancouver BC Canada

Child Life and Health University of Edinburgh Edinburgh UK

Department of Paediatrics University Hospital Motol Prague Czech Republic

Department of Woman Child and General and Specialistic Surgery University of Campania Luigi Vanvitelli Napoli Italy

Erasmus MC Sophia Children's Hospital Rotterdam The Netherlands

Helsinki University Children's Hospital Department of Pediatric Surgery Helsinki Finland

Hospital Sant Joan de Déu Barcelona Spain

National Children's Research Centre Royal College of Surgeons of Ireland and University College Dublin Dublin Ireland

Pediatric Department University of Messina Messina Italy

Pediatric Gastroenterology and Liver Unit Sapienza University of Rome Rome Italy

Pediatric Gastroenterology and Nutrition Unit Hospital Materno IBIMA Málaga Spain

Schneider Children's Hospital Petach Tikva Affiliated to the Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

School of Medical Sciences Ioannina University of Ioannina Ioannina Greece

Shaare Zedek Medical Center The Hebrew University of Jerusalem Jerusalem Israel

Southampton Children's Hospital Southampton UK

The Hospital for Sick Children University of Toronto Toronto Canada

The Royal Hospital for Children Glasgow UK

Université Paris Descartes Sorbonne Paris Cité APHP Hôpital Necker Enfants Malades Paris France

University Children's Hospital Zurich Switzerland

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045346
003      
CZ-PrNML
005      
20200115091446.0
007      
ta
008      
200109s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MPG.0000000000002035 $2 doi
035    __
$a (PubMed)30044357
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Turner, Dan $u Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
245    10
$a Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition / $c D. Turner, FM. Ruemmele, E. Orlanski-Meyer, AM. Griffiths, JM. de Carpi, J. Bronsky, G. Veres, M. Aloi, C. Strisciuglio, CP. Braegger, A. Assa, C. Romano, S. Hussey, M. Stanton, M. Pakarinen, L. de Ridder, K. Katsanos, N. Croft, V. Navas-López, DC. Wilson, S. Lawrence, RK. Russell,
520    9_
$a BACKGROUND: The contemporary management of ambulatory ulcerative colitis (UC) continues to be challenging with ∼20% of children needing a colectomy within childhood years. We thus aimed to standardize daily treatment of pediatric UC and inflammatory bowel diseases (IBD)-unclassified through detailed recommendations and practice points. METHODS: These guidelines are a joint effort of the European Crohn's and Colitis Organization (ECCO) and the Paediatric IBD Porto group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). An extensive literature search with subsequent evidence appraisal using robust methodology was performed before 2 face-to-face meetings. All 40 included recommendations and 86 practice points were endorsed by 43 experts in Paediatric IBD with at least an 88% consensus rate. RESULTS: These guidelines discuss how to optimize the use of mesalamine (including topical), systemic and locally active steroids, thiopurines and, for more severe disease, biologics. The use of other emerging therapies and the role of surgery are also covered. Algorithms are provided to aid therapeutic decision-making based on clinical assessment and the Paediatric UC Activity Index (PUCAI). Advice on contemporary therapeutic targets incorporating the use of calprotectin and the role of therapeutic drug monitoring are presented, as well as other management considerations around pouchitis, extraintestinal manifestations, nutrition, growth, psychology, and transition. A brief section on disease classification using the PIBD-classes criteria and IBD-unclassified is also part of these guidelines. CONCLUSIONS: These guidelines provide a guide to clinicians managing children with UC and IBD-unclassified management to provide modern management strategies while maintaining vigilance around appropriate outcomes and safety issues.
650    _2
$a ambulantní péče $x normy $7 D000553
650    _2
$a dítě $7 D002648
650    _2
$a fyziologie výživy dětí $7 D002664
650    _2
$a ulcerózní kolitida $x diagnóza $x terapie $7 D003093
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a společnosti lékařské $7 D012955
651    _2
$a Evropa $7 D005060
655    _2
$a konsensus - konference $7 D016446
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
700    1_
$a Ruemmele, Frank M $u Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, Paris, France.
700    1_
$a Orlanski-Meyer, Esther $u Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
700    1_
$a Griffiths, Anne M $u The Hospital for Sick Children, University of Toronto, Toronto, Canada.
700    1_
$a de Carpi, Javier Martin $u Hospital Sant Joan de Déu, Barcelona, Spain.
700    1_
$a Bronsky, Jiri $u Department of Paediatrics, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Veres, Gabor $u 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary.
700    1_
$a Aloi, Marina $u Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.
700    1_
$a Strisciuglio, Caterina $u Department of Woman, Child and General and Specialistic Surgery, University of Campania "Luigi Vanvitelli," Napoli, Italy.
700    1_
$a Braegger, Christian P $u University Children's Hospital, Zurich, Switzerland.
700    1_
$a Assa, Amit $u Schneider Children's Hospital, Petach Tikva, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
700    1_
$a Romano, Claudio $u Pediatric Department, University of Messina, Messina, Italy.
700    1_
$a Hussey, Séamus $u National Children's Research Centre, Royal College of Surgeons of Ireland and University College Dublin, Dublin, Ireland.
700    1_
$a Stanton, Michael $u Southampton Children's Hospital, Southampton, UK.
700    1_
$a Pakarinen, Mikko $u Helsinki University Children's Hospital, Department of Pediatric Surgery, Helsinki, Finland.
700    1_
$a de Ridder, Lissy $u Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
700    1_
$a Katsanos, Konstantinos $u School of Medical Sciences Ioannina, University of Ioannina, Ioannina, Greece.
700    1_
$a Croft, Nick $u Barts and the London School of Medicine, Queen Mary University of London, London, UK.
700    1_
$a Navas-López, Victor $u Pediatric Gastroenterology and Nutrition Unit. Hospital Materno, IBIMA, Málaga, Spain.
700    1_
$a Wilson, David C $u Child Life and Health, University of Edinburgh, Edinburgh, UK.
700    1_
$a Lawrence, Sally $u BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
700    1_
$a Russell, Richard K $u The Royal Hospital for Children, Glasgow, UK.
773    0_
$w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 67, č. 2 (2018), s. 257-291
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30044357 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200115091820 $b ABA008
999    __
$a ok $b bmc $g 1483615 $s 1084019
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 67 $c 2 $d 257-291 $e - $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
GRA    __
$a G0800675 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...